Tiziana Files For Orphan Drug Designation For Foralumab In MSA
(RTTNews) - Wednesday, Tiziana Life Sciences (TLSA) said it submitted a request to the FDA for Orphan Drug Designation for intranasal foralumab for the treatment of Multiple System Atrophy (MSA).